Skip to main content

Find Clinical Trials

Home
Conditions
Hyperkalemia

Clinical trial condition

Hyperkalemia

Explore clinical trials studying Hyperkalemia. Study availability and eligibility vary by location and protocol.

104 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Hyperkalemia trial results

Completed

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects

NCT05136664

Conditions: Chronic Disease, Disease Attributes, Female Urogenital Diseases, +13 more
Locations: Investigator Site 009 Hefei, Anhui, China

Investigator Site 008 Hefei, Anhui, China

Investigator Site 016 Beijing, Beijing Municipality, China

Investigator Site 012 Lanzhou, Gansu, China

View all 28 locations

View Trial Details

Completed

Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG

NCT07054905

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Chungnam National University Hospital Daejeon, South Korea

View Trial Details

Completed

A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

NCT06185660

Conditions: Hyperkalaemia, Hyperkalemia, Metabolic Diseases, +2 more
Locations: Research Site Alexandroupoli, Greece

Research Site Athens, Greece

Research Site Athens, Greece

Research Site Athens, Greece

View Trial Details

Completed

5 Versus 10 Units of Insulin in Hyperkalemia Management

NCT06036823

Conditions: Electrolyte Disturbance, Electrolyte Imbalance, Glucose Metabolism Disorders, +7 more
Locations: Sultan Qaboos University hospital Seeb, Muḩāfaz̧at Masqaţ, Oman

View Trial Details

Completed

Nurse-Led Nutritional Education for Moroccan Dialysis Patients

NCT07277530

Conditions: Chronic Kidney Disease 5D, Hemodialysis, Hyperkalemia, +3 more
Locations: Settat Hemodialysis Center,el borouj Hemodialysis Center, Al amal Hemodialysis Center Settat, Morocco

View Trial Details

Completed

Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

NCT05347693

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations: Research Site Bonheiden, Belgium

Research Site Leuven, Belgium

Research Site Annonay, France

Research Site Ars-Laquenexy, France

View all 28 locations

View Trial Details

Completed

An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure

NCT05297409

Conditions: Hyperkalemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Research Site Kasugai, Aichi-ken, Japan

Research Site Nagaoka, Aichi-ken, Japan

Research Site Nagaoka, Aichi-ken, Japan

Research Site Matsudo, Chiba, Japan

View all 32 locations

View Trial Details

Completed

Tracking Treatment Pathways in Adult Patients With Hyperkalemia.

NCT05408039

Conditions: Cardiovascular Diseases, Chronic Disease, Disease Attributes, +16 more
Locations: Research Site Huntsville, Alabama, United States

Research Site La Jolla, California, United States

Research Site Rancho Cucamonga, California, United States

Research Site New Haven, Connecticut, United States

View all 74 locations

View Trial Details

Completed

Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone

NCT04676646

Conditions: Heart Failure With Reduced Ejection Fraction, Hyperkalaemia, Hyperkalemia, +3 more
Locations: Research Site Fairhope, Alabama, United States

Research Site Los Angeles, California, United States

Research Site Torrance, California, United States

Research Site Evanston, Illinois, United States

View all 89 locations

View Trial Details

Completed

Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients

NCT03781089

Conditions: Chronic Disease, Disease Attributes, End Stage Renal Disease, +15 more
Locations: DaVita Dialysis Sites Durham, North Carolina, United States

View Trial Details